Sarepta Therapeutics: Navigating Crisis and Market Reactions

This chapter explores the challenges faced by Sarepta Therapeutics concerning its muscular dystrophy drug Elevitus, including workforce layoffs and FDA scrutiny. Despite these setbacks, the company's shares rise due to resolution of uncertainties around the drug's future.